Search
Accendra Health Ord Shs
ACHAdd to Watchlist
3.230USD
+0.085+2.69%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
246.73MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
5
analysts
Hold
Current Rating
4.490
Target Price
+39.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Accendra Health Ord Shs
ACH
5
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Accendra Health Ord Shs's expected revenue for the next quarter?
Accendra Health Ord Shs's expected revenue is 627.37M.
How have Accendra Health Ord ShsACH's recent earnings per share performed?
The market expectation was USD -0.08, while Accendra Health Ord ShsACH's earnings per share (EPS) for the previous quarter was USD -0.74. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for Accendra Health Ord Shs?
Based on the ratings of Accendra Health Ord Shs's stock from 5 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
